Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 8.62B | 9.56B | 9.18B | 8.15B | 8.50B | 8.39B |
| Cost of revenue | 2.74B | 3.08B | 3.01B | 2.97B | 3.31B | 3.24B |
| Selling, general and administrative | 1.60B | 1.72B | 1.69B | 1.69B | 1.63B | 1.79B |
| Operating expenses | 5.95B | 7.03B | 6.52B | 6.97B | 6.46B | 6.48B |
| Operating income | 2.67B | 2.53B | 2.66B | 1.18B | 2.05B | 1.91B |
| Interest expense | 657M | 685M | 694M | 723M | 776M | 808M |
| Pre-tax income | 2.08B | 3.92B | 1.57B | 1.97B | 3.10B | 794M |
| Income tax | 265M | 705M | 136M | 243M | 271M | 48M |
| Net income | 1.82B | 3.22B | 1.43B | 1.73B | 2.83B | 746M |
| Earnings per share | 3.37 | 5.98 | 2.66 | 3.22 | 5.27 | 1.39 |
| Earnings per share, diluted | 3.34 | 5.93 | 2.65 | 3.20 | 5.22 | 1.38 |
| Weighted average shares | 540M | 538M | 538M | 538M | 537M | 537M |
| Weighted average shares, diluted | 544M | 542M | 541M | 541M | 542M | 541M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 12.04B | 9.13B | 9.45B | 8.03B | 8.81B | 11.97B | 9.01B | 9.30B |
| Receivables | 9.14B | 9.57B | 8.49B |
| Metric | 31 Mar 2026 | 31 Mar 2025 |
|---|---|---|
| Operating cash flow | 2.19B | 1.39B |
| Depreciation and amortisation | 1.12B | 1.39B |
| Share-based compensation | 75M | 85M |
| Capital expenditure | 712M | 411M |
| Investing cash flow | −716M | −447M |
| Dividends paid | 1.36B |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 8.70B |
| 8.13B |
| 6.78B |
| 7.32B |
| 6.93B |
| Inventory | 6.19B | 6.23B | 6.35B | 6.58B | 6.73B | 7.00B | 7.36B | 8.00B |
| Current assets | 31.48B | 29.06B | 27.89B | 26.73B | 26.93B | 29.03B | 26.77B | 27.21B |
| Property, plant and equipment | 8.22B | 7.91B | 7.22B | 6.86B | 6.68B | 6.54B | 6.16B | 6.10B |
| Goodwill | 18.67B | 18.68B | 18.68B | 18.67B | 18.65B | 18.64B | 18.66B | 18.62B |
| Total assets | 92.50B | 90.59B | 90.14B | 87.90B | 89.37B | 91.84B | 90.88B | 90.91B |
| Current liabilities | 24.96B | 25.49B | 21.79B | 20.48B | 23.01B | 23.10B | 20.31B | 21.52B |
| Short-term debt | 5.44B | 4.60B | 2.15B | 2.44B | 3.37B | 3.55B | 3.54B | 5.53B |
| Long-term debt | 51.89B | 50.01B | 52.43B | 53.76B | 54.01B | 56.55B | 56.85B | 57.12B |
| Equity | 9.19B | 8.66B | 9.62B | 7.43B | 6.21B | 5.88B | 7.53B | 5.93B |
| Shares outstanding | 540M | 539M | 539M | 538M | 538M | 537M | 538M | 537M |
| 1.28B |
| Financing cash flow | 1.44B | −4.11B |